While TRAIL and its receptors have been implicated in cancer for decades, emerging evidence suggests a role in a multitude of different diseases including arthritis, diabetes and cardiovascular disease (Benedict and Ware, 2012). This evidence concerns the gene TNFSF10 and cardiovascular disorder.